The DEA, COVID-19, and the Opioid Crisis by GW Regulatory Studies Ctr published on 2020-10-02T12:59:26Z Laura Stanley discusses recent and upcoming regulatory actions from the Drug Enforcement Administration that could play a role in combating the opioid crisis. Related publications written by Laura: Washington Post op-ed: Bring Back the Methadone Vans https://www.washingtonpost.com/opinions/2020/03/20/coronavirus-is-upending-society-here-are-ideas-mitigate-its-impact/?arc404=true#Stanley Commentary: Regulations Teed Up at the DEA https://regulatorystudies.columbian.gwu.edu/regulations-teed-dea Public Interest Comment: DEA's Mobile Narcotic Treatment Program https://regulatorystudies.columbian.gwu.edu/deas-mobile-narcotic-treatment-program Genre Learning
